Cancer-specific survival and prognostic factors
Among patients with SLM, approximately 96.4% and 74.8% of them respectively received systemic treatment and surgery during the first-course treatment. While approximately 12.2% of them received radiotherapy. The median CSS was 25 months (95% CI 21–32 months, 